FIELD: pharmacology.
SUBSTANCE: dry powder inhalation compositions containing spray-dried particles and their use for treatment of obstructive or inflammatory respiratory disease are described. Each particle has a core of the first active ingredient in a substantially crystalline form that is coated by a layer of the second active ingredient in a substantially amorphous form that is dispersed in a pharmaceutically acceptable hydrophobic excipient. The hydrophobic excipient is a phospholipid in an amount of 40 to 99 wt % of the composition. A method for preparation of such compositions and a delivery system comprising an inhaler and a dry powder composition are also described.
EFFECT: invention solves the problem of co-formulating two or more pharmaceutically active agents in a single powder dosage form that is suitable for inhalation, with improved aerosol characteristics.
15 cl, 3 dwg, 9 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING | 2014 |
|
RU2698331C2 |
ORGANIC COMPOUNDS | 2008 |
|
RU2496479C2 |
COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | 2010 |
|
RU2586297C2 |
AGGREGATED PARTICLES | 2013 |
|
RU2666963C2 |
DIRECTED DELIVERY OF SPRAY-DRIED COMPOSITIONS INTO THE LUNGS | 2016 |
|
RU2731212C2 |
METHOD FOR PRODUCING LOW-STATIC PARTICLES | 2011 |
|
RU2580312C2 |
INHALATION COMPOSITIONS CONTAINING MONTELEUKAST ACID AND PDE-4 INHIBITOR OR INHALATION CORTICOSTEROID | 2008 |
|
RU2470639C2 |
CRYSTALLINE MICRO PARTICLES OF BETA-AGONIST, COATED WITH FATTY ACID | 2012 |
|
RU2629085C2 |
METHOD OF PROCESSING PARTICLES OF ACTIVE PHARMACEUTICAL INGREDIENTS | 2011 |
|
RU2597790C2 |
METHOD FOR PRODUCING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATIONS | 2011 |
|
RU2585101C2 |
Authors
Dates
2017-08-28—Published
2012-02-03—Filed